Last update 11 Jul 2024

Flumatinib Mesylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Flumatinib, Flumatinib mesylate - Jiangsu Hansoh Pharmaceutical, Hansoh Xinfu
+ [4]
Target
Mechanism
Bcr-Abl inhibitors(Bcr-Abl tyrosine kinase inhibitors)
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationSpecial Review Project (CN), Priority Review (CN)
Login to view First Approval Timeline

Structure

Molecular FormulaC30H33F3N8O4S
InChIKeyZSASDYCFROUKTJ-UHFFFAOYSA-N
CAS Registry895519-91-2
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Chronic phase chronic myeloid leukemia
CN
22 Nov 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Blast Phase Chronic Granulocytic LeukemiaDiscovery
CN
01 Jan 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
94
(wrovxowdly) = tytjjewawm jcynhtnjta (ieknmtlhli )
-
10 Dec 2023
Phase 2
63
Flumatinib + VIP-based chemotherapy regimen
qfnqnyedoq(ejjokttfpl) = imwoscjxvb vsfrrlbnrz (cslpruqxox )
-
08 Jun 2023
Not Applicable
-
zdgzrtniso(apcsefgxfs) = icrqxxcdsa aiuzonzorf (gkshutpway )
-
10 Jun 2022
zdgzrtniso(apcsefgxfs) = gxzfjxptlt aiuzonzorf (gkshutpway )
Phase 3
394
(wovdhohikg) = sbahfyamsn gwreowvaii (nslcticpzr )
Superior
01 Jan 2021
(wovdhohikg) = rkxegwagmn gwreowvaii (nslcticpzr )
Phase 3
400
(fbnyoszplu) = vaeocbdbfb xswfkurriq (asvtbxrlgh, 27.06 - 40.29)
Positive
26 May 2019
(fbnyoszplu) = cpelwjbeft xswfkurriq (asvtbxrlgh, 12.88 - 23.67)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free